Structure-activity relationship between carboxylic acids and T cell cycle blockade

Life Sciences

Volumn 78, Issue 19, 2006, Pages 2159-2165

  Gilbert, Kathleen M ^a   Deloose, Annick ^a   Valentine, Jimmie L ^b   Fifer, E Kim ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Carboxylic acids; Histone deacetylase; n Butyrate; p21cip1

Indexed keywords

BUTYRIC ACID; CARBOXYLIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE DEACETYLASE; REGULATOR PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL CYCLE PROGRESSION; CYTOTOXIC T LYMPHOCYTE; DEACETYLATION; ENZYME REGULATION; MALE; MOUSE; NONHUMAN; STRUCTURAL HOMOLOGY; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; TH1 CELL; WESTERN BLOTTING;

ACETYLATION; ANIMALS; CARBOXYLIC ACIDS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HISTONES; MALE; MICE; MICE, INBRED C57BL; STRUCTURE-ACTIVITY RELATIONSHIP; TH1 CELLS; UP-REGULATION;

EID: 33645233142     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.09.047     Document Type: Article

References (33)

1. O. Aprelikova, Y. Xiong, and E.T. Liu Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase Journal of Biological Chemistry 270 1995 18195 18197
2. S.Y. Archer, S. Meng, A. Shei, and R.A. Hodin p21(Waf1) is required for butyrate-mediated growth inhibition of human colon cancer cells Proceedings of the National Academy of Sciences 95 1998 6791 6796
3. L. Bai, and J.L. Merchant Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells Journal of Biological Chemistry 29 2000 30725 30733
4. J.A. Barnard, and G. Warwick Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells Cell Growth and Differentiation 4 1993 495 501
5. S.A. Belinsky, D.M. Klinge, C.A. Stidley, J.P. Issa, J.G. Herman, T.H. March, and S.B. Baylin Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer Cancer Research 63 2003 7089 7093
6. L.C. Boffa, G. Vidali, R.S. Mann, and V.G. Allfrey Suppression of histone deacetylation in vivo and in vitro by sodium butyrate Journal of Biological Chemistry 253 1978 3364 3366
7. Waf1 Pathologie et Biologie 48 2000 190 202
8. C. Buquet-Fagot, F. Lallemond, R.H. Charollais, and J. Mester Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent manner Journal of Cellular Physiology 166 1996 631 636
9. E.P. Candido, R. Reeves, and J.R. Davie Sodium butyrate inhibits histone deacetylation in cultured cells Cell 14 1978 105 113
10. D. Chen, V. Heath, A. O'Garra, J. Johnston, and M. McMahon Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells Journal of Immunology 163 1999 5796 5805
11. Y.X. Chen, J.Y. Fang, J. Lu, and D.K. Qiu Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines Zhonghua YiXue ZaZhi 84 2004 312 317
12. Y.X. Chen, J.Y. Fang, H.Y. Zhu, R. Lu, Z.H. Cheng, and D.K. Qiu Histone acetylation regulates p21(WAF1) expression in human colon cancer cell lines World Journal of Gastroenterology 10 2004 2643 2646
13. J.R. Davie Inhibition of histone deacetylase activity by butyrate Journal of Nutrition 133 2003 2485S 2493S
14. E.J. Firpo, A. Koff, M.J. Solomon, and J.M. Roberts Inactivation of a Cdk2 inhibitor during interleukin-2-induced proliferation of human T lymphocytes Molecular and Cellular Biology 14 1994 4889 4901
15. K.M. Gilbert, K.D. Hoang, and W.O. Weigle Th1 and Th2 clones differ in their response to a tolerogenic signal Journal of Immunology 144 1990 2063 2071
16. kip1 Journal of Immunology 166 2001 952 958
17. S.K. Jackson, A. DeLoose, and K.M. Gilbert The ability of antigen, but not IL-2, to promote n-butyrate-induced Th1 cell anergy is associated with increased expression and altered association patterns of cyclin dependent kinase inhibitors Immunology 106 2002 486 495
18. J. Kruh Effects of sodium butyrate, a new pharmacological agent, on cells in culture Molecular and Cellular Biochemistry 42 1982 65
19. D.A. Litvak, B.M. Evers, K.O. Hwang, M.R. Hellmich, T.C. Ko, and C.M. Townsend Jr. Butyrate-induced differentiation of Caco-2 cells is associated with apopotosis and early induction of p21Waf1/Cip1 and p27Kip1 Surgery 124 1998 161 169
20. Q. Lu, Y.T. Yang, C.S. Chen, M. Davis, J.C. Byrd, M.R. Etherton, A. Umar, and C.S. Chen Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors Journal of Medicinal Chemistry 47 2004 467 474
21. K. Nakano, T. Mizuno, Y. Sowa, T. Orita, T. Yoshino, Y. Okuyama, T. Fujita, N. Ohtani-Fujita, Y. Matsukawa, T. Tokino, H. Yamagishi, T. Oka, H. Nomura, and T. Sakai Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line Journal of Biological Chemistry 272 1997 22199 22206
22. J. Nourse, E. Firpo, W.M. Flanagan, S. Coats, K. Polyak, M.H. Lee, J. Massague, G.R. Crabtree, and J.M. Roberts Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin Nature 372 1994 570 573
23. P. Planchon, H. Raux, V. Magnien, G. Ronco, P. Villa, M. Crepin, and D. Brouty-Boye New stable butyrate derivatives alter proliferation and differentiation in human mammary cells International Journal of cancer 48 1991 443 449
24. S.F. Rashid, J.S. Moore, E. Walker, P.M. Driver, J. Engel, C.E. Edwards, G. Brown, M.R. Uskokovic, and M.J. Campbell Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A Oncogene 20 2001 1860 1872
25. V.M. Richon, T.W. Sandhoff, R.A. Rifkind, and P.A. Marks Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation Proceedings of the National Academy of Sciences of the United States of America 97 2000 10014 10019
26. Y. Sowa, T. Orita, S. Minamikawa, K. Nakano, T. Mizuno, H. Nomura, and T. Sakai Histone deaceylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 site Biochemical and Biophysical Research Communications 241 1997 142 150
27. C. Vaziri, L. Stice, and D.V. Faller Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals Cell Growth and Differentiation 9 1998 465 474
28. G. Vidali, L.C. Boffa, E.M. Bradbury, and V.G. Allfrey Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences Proceedings of the National Academy of Sciences of the United States of America 75 1978 2239 2243
29. R.P. Warrell Jr., L.Z. He, V. Richon, E. Calleja, and P.P. Pandolfi Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase Journal of the National Cancer Institute 90 1998 1621 1625
30. E. Wintersberger, I. Mudrak, and U. Wintersberger Butyrate inhibits mouse fibroblasts at a control point in the G1 phase Journal of Cellular Biochemistry 21 1983 239 247
31. H. Xiao, T. Hasegawa, O. Miyaishi, K. Ohkusu, and K. Isobe Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner Biochemical and Biophysical Research Communications 237 1997 457 460
32. S. Xue, and P.N. Rao Sodium butyrate blocks HeLa cells preferentially in early G1 phase of the cell cycle Journal of Cell Science 51 1981 163 171
33. W. Yasui, N. Oue, S. Ono, Y. Mitani, R. Ito, and H. Nakayama Histone acetylation and gastrointestinal carcinogenesis Annals of the New York Academy of Sciences 983 2003 220 231